1.
La Leggia L. Multiple Sclerosis and Nabiximols at the times of COVID-19. EJCRIM [Internet]. 2021 Oct. 11 [cited 2026 Nov. 3];8(S2). Available from: https://ejcrim.com/index.php/ejcrim/article/view/2985